[Federal Register Volume 76, Number 125 (Wednesday, June 29, 2011)]
[Notices]
[Page 38209]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2011-16286]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Importer of Controlled Substances; Notice of Registration

    By Notice dated April 11, 2011, and published in the Federal 
Register on April 19, 2011, 76 FR 21915, Meda Pharmaceuticals, Inc., 
705 Eldorado Street, Decatur, Illinois 62523, made application by 
renewal to the Drug Enforcement Administration (DEA) to be registered 
as an importer of Nabilone (7379), a basic class of controlled 
substance listed in schedule II.
    The company plans to import the listed controlled substance as a 
finished drug product in dosage form only for distribution to its 
customers. The company does not import the listed controlled substance 
in bulk active pharmaceutical ingredient (API) form.
    There are no domestic sources of Nabilone in finished drug product 
form available in the United States. The U.S. Food and Drug 
Administration has approved this product for medical use in the United 
States.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and Sec.  952(a), and determined that 
the registration of Meda Pharmaceuticals Inc. to import the basic class 
of controlled substance is consistent with the public interest, and 
with United States obligations under international treaties, 
conventions, or protocols in effect on May 1, 1971. DEA has 
investigated Meda Pharmaceuticals Inc. to ensure that the company's 
registration is consistent with the public interest. The investigation 
has included inspection and testing of the company's physical security 
systems, verification of the company's compliance with state and local 
laws, and a review of the company's background and history. Therefore, 
pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 
1301.34, the above named company is granted registration as an importer 
of the basic class of controlled substance listed.

    Dated: June 22, 2011.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2011-16286 Filed 6-28-11; 8:45 am]
BILLING CODE 4410-09-P